Developing and expanding hospital antimicrobial stewardship: The Ontario experience.

Y. Nakamachi, S. West, L. Dresser, Andrew M. Morris
{"title":"Developing and expanding hospital antimicrobial stewardship: The Ontario experience.","authors":"Y. Nakamachi, S. West, L. Dresser, Andrew M. Morris","doi":"10.14745/CCDR.V41IS4A04","DOIUrl":null,"url":null,"abstract":"Mount Sinai Hospital and University Health Network, two academic health science centres in Toronto, Ontario, jointly established a robust, well-resourced antimicrobial stewardship program (ASP). Over the course of four years, we spread our program to five intensive care units (ICUs), learned which change management practices worked and which did not, and leveraged our ICU successes to other areas of our hospitals. We identified the following two factors as critical to establishing ASPs in hospitals: strong leadership with clear accountability; and valid, reliable data to monitor progress. Subsequently we have led the spread of our program to 14 academic hospital ICUs, and more recently we leveraged to help community hospitals implement ASPs without in-house infectious diseases specialists. We introduced three new data fields into the provincial critical care information system: days of antibacterial therapy, days of antifungal therapy, and ICU-onset C. difficile, which will help standardize data collection moving forward. This model-starting with academic health sciences centres, and antimicrobial stewardship experts and leaders who are then supported to mentor and develop new experts and leaders-could be copied in other jurisdictions both within and outside of Canada.","PeriodicalId":94304,"journal":{"name":"Canada communicable disease report = Releve des maladies transmissibles au Canada","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canada communicable disease report = Releve des maladies transmissibles au Canada","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14745/CCDR.V41IS4A04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Mount Sinai Hospital and University Health Network, two academic health science centres in Toronto, Ontario, jointly established a robust, well-resourced antimicrobial stewardship program (ASP). Over the course of four years, we spread our program to five intensive care units (ICUs), learned which change management practices worked and which did not, and leveraged our ICU successes to other areas of our hospitals. We identified the following two factors as critical to establishing ASPs in hospitals: strong leadership with clear accountability; and valid, reliable data to monitor progress. Subsequently we have led the spread of our program to 14 academic hospital ICUs, and more recently we leveraged to help community hospitals implement ASPs without in-house infectious diseases specialists. We introduced three new data fields into the provincial critical care information system: days of antibacterial therapy, days of antifungal therapy, and ICU-onset C. difficile, which will help standardize data collection moving forward. This model-starting with academic health sciences centres, and antimicrobial stewardship experts and leaders who are then supported to mentor and develop new experts and leaders-could be copied in other jurisdictions both within and outside of Canada.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
发展和扩大医院抗菌药物管理:安大略省的经验。
西奈山医院和大学卫生网络是安大略省多伦多的两个学术卫生科学中心,共同建立了一个强大的、资源充足的抗菌药物管理规划(ASP)。在四年的时间里,我们将这个项目推广到五个重症监护室(ICU),了解到哪些管理变革行之有效,哪些无效,并将ICU的成功推广到医院的其他领域。我们确定了以下两个因素对于在医院建立asp至关重要:强有力的领导和明确的问责制;以及有效、可靠的数据来监测进展。随后,我们将我们的项目推广到14家学术医院的icu,最近,我们帮助社区医院在没有内部传染病专家的情况下实施asp。我们在省级重症监护信息系统中引入了三个新的数据字段:抗菌治疗天数、抗真菌治疗天数和重症监护病房发病艰难梭菌,这将有助于标准化数据收集。这种模式——从学术卫生科学中心和抗微生物药物管理专家和领导者开始,然后支持他们指导和培养新的专家和领导者——可以在加拿大境内外的其他司法管辖区复制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
An innovative tool to prioritize the assessment of investigational COVID-19 therapeutics: A pilot project. Evidence brief on facilitators, barriers and hesitancy of COVID-19 booster doses in Canada. Large scale analysis of the SARS-CoV-2 main protease reveals marginal presence of nirmatrelvir-resistant SARS-CoV-2 Omicron mutants in Ontario, Canada, December 2021-September 2023. Lessons learned from COVID-19: Harnessing community insights for better vaccination outcomes. Mathematical modelling for pandemic preparedness in Canada: Learning from COVID-19.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1